GYS1, NDUFA11, OXSM, RPN1, and SLC3A2 play a role in promoting cancer in glioma, while LRPPRC, NCKAP1, NDUFS1, NUBPL and SLC7A11 play a role in inhibiting tumour. Here, SLC3A2 is linked to neoplasm.